Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    An Enquiry

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Asfotase Alfa

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AstraZeneca’s Strensiq successor misses ph. 3 rare disease goal
    AstraZeneca’s Strensiq successor misses ph. 3 rare disease goal

    01 Apr 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/astrazenecas-phase-3-rare-disease-trial-misses-goal-denting-market-expansion-plan

    FIERCE BIOTECH
    01 Apr 2026
    Share Share
    Alexion Pharma's Biologic Strensiq (asfotase alfa) Receives Approval in US
    Alexion Pharma's Biologic Strensiq (asfotase alfa) Receives Approval in US

    10 Jul 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125513

    FDA
    10 Jul 2024
    Share Share
    NICE recommends Alexion’s asfotase alfa across England
    NICE recommends Alexion’s asfotase alfa across England

    27 Jan 2023

    // PHARMATIMES

    https://www.pharmatimes.com/news/nice_recommends_alexions_asfotase_alfa_across_england_1485973

    PHARMATIMES
    27 Jan 2023
    Share Share
    Alexion`s Strensiq (Asfotase Alfa) Receives Supplemental Approval in US
    Alexion`s Strensiq (Asfotase Alfa) Receives Supplemental Approval in US

    17 Jun 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125513

    FDA
    17 Jun 2020
    Share Share
    Abeona Therapeutics Announces Leadership Appts with Max Colao as CCO
    Abeona Therapeutics Announces Leadership Appts with Max Colao as CCO

    30 Jul 2018

    // GLOBENEWSWIRE

    https://globenewswire.com/news-release/2018/07/26/1542695/0/en/Abeona-Therapeutics-Announces-Leadership-Appointments-with-Max-Colao-as-Chief-Commercial-Officer.html

    GLOBENEWSWIRE
    30 Jul 2018
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.